Save on Bimekizumab with Coupons, Discounts & Savings Programs

Bimekizumab is available as

Bimekizumab is an interleukin antagonist and is used to treat moderate-to-severe plaque psoriasis in adults.

Bimekizumab is a monoclonal antibody known as an interleukin receptor antagonist. It blocks interleukin-17A and interleukin-17F (IL-17A, IL-17F), which are proteins that are part of your immune system and are responsible for inflammation (redness and swelling). By blocking these proteins, Bimekizumab calms down the immune system. As a result, it can help ease symptoms of itchy skin and skin redness due to plaque psoriasis.

The typical starting dose is two 160 mg injections under the skin every month for the first 5 doses. After that, the typical maintenance dose is two 160 mg injections under the skin every other month. If you weigh 264 pounds or more, your provider might consider a maintenance dose of two 160 mg injections every month.

Bimekizumab is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you have

Common side effects of Bimekizumab:

• Upper respiratory tract infection
• Oral thrush
• Headache
• Injection site reactions
• Fungal skin infections

Serious side effects are rare with Bimekizumab. Contact your healthcare provider immediately if you experience any of the following.

• Tuberculosis (TB): coughing up blood or mucus, weight loss, feeling tired or weak, fever, chills, night sweats
• Other serious infections: fever, cough, chills, sore throat, runny or stuffy nose, body aches
• Liver problems: nausea, vomiting, not feeling hungry, pain in the right side of the stomach, yellowing of the whites of the eyes or skin, dark-colored urine, light-colored stool

The following medications may interact with Bimekizumab:

Various FDA-approved generic manufacturers

It is not known if Bimekizumab will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking Bimekizumab.You’re encouraged to enroll in a pregnancy exposure registry that monitors and collects information about your and your baby’s health. Learn more about this pregnancy exposure registry by calling 1-877-311-8972.

• Bimzelx